Federated Hermes’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139M | Buy |
|
|||||
|
2025
Q1 | $5.34M | Buy |
|
|||||
|
2024
Q4 | $3.08M | Sell |
|
|||||
|
2024
Q3 | $4.45M | Buy |
|
|||||
|
2024
Q2 | $4.16M | Sell |
|
|||||
|
2024
Q1 | $8.67M | Sell |
|
|||||
|
2023
Q4 | $7.91M | Sell |
|
|||||
|
2023
Q3 | $7.95M | Buy |
|
|||||
|
2023
Q2 | $4.76M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $5.39M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $84.8M | Sell |
|
|||||
|
2020
Q2 | $113M | Sell |
|
|||||
|
2020
Q1 | $128M | Sell |
|
|||||
|
2019
Q4 | $184M | Buy |
|
|||||
|
2019
Q3 | $166M | Sell |
|
|||||
|
2019
Q2 | $157M | Sell |
|
|||||
|
2019
Q1 | $165M | Sell |
|
|||||
|
2018
Q4 | $154M | Buy |
|
|||||
|
2018
Q3 | $161M | Sell |
|
|||||
|
2018
Q2 | $176M | Buy |
|
|||||
|
2018
Q1 | $168M | Sell |
|
|||||
|
2017
Q4 | $179M | Sell |
|
|||||
|
2017
Q3 | $222M | Buy |
|
|||||
|
2017
Q2 | $195M | Buy |
|
|||||
|
2017
Q1 | $155M | Sell |
|
|||||
|
2016
Q4 | $144M | Sell |
|
|||||
|
2016
Q3 | $242M | Sell |
|
|||||
|
2016
Q2 | $272M | Buy |
|
|||||
|
2016
Q1 | $228M | Sell |
|
|||||
|
2015
Q4 | $249M | Sell |
|
|||||
|
2015
Q3 | $268M | Sell |
|
|||||
|
2015
Q2 | $292M | Buy |
|
|||||
|
2015
Q1 | $264M | Buy |
|
|||||
|
2014
Q4 | $230M | Buy |
|
|||||
|
2014
Q3 | $227M | Buy |
|
|||||
|
2014
Q2 | $227M | Buy |
|
|||||
|
2014
Q1 | $180M | Buy |
|
|||||
|
2013
Q4 | $170M | Buy |
|
|||||
|
2013
Q3 | $155M | Buy |
|
|||||
|
2013
Q2 | $152M | Buy |
|